FundersVisit website
Uncle Kory Foundation
Foundation · El Segundo, California, United States
- 0
- Open now
- $586K
- Given in 2025
- $50K
- Typical grant
- Invitation only
- Takes applications
- $888K
- Assets
Open now
Nothing open right now.
Where the money went
2025 tax return
- $25K
- Research, 1 grant
- $475K
- Universities, 11 grants
- City of Hope$50K
Targeting non-coding rna pseudouridine modification for glioblastoma therapy
- Cornell University$50K
To fund project "regulation of myeloid cells by fatty acid metabolism in irradiated glioblastoma." 2nd year renewal
- Duke University$50K
Sirpiglenastat for treating glioblastoma
- Regents University of California Los Angeles$50K
Characterizing ptprz1 mechanism in cancer as a therapeutic target, 3rd year funding
- The UCLA Foundation$50K
Hapten-modified neoantigens as immune targets for glioblastoma treatment
All 16 grants
| Recipient | Purpose | Amount |
|---|---|---|
| The Mark Foundation for Cancer ResearchNew York, NY | Foundation gift for the gbm initiative | $25K |
| City of HopeDuarte, CA | Targeting non-coding rna pseudouridine modification for glioblastoma therapy | $50K |
| Cornell UniversityIthaca, NY | To fund project "regulation of myeloid cells by fatty acid metabolism in irradiated glioblastoma." 2nd year renewal | $50K |
| Duke UniversityDurham, NC | Sirpiglenastat for treating glioblastoma | $50K |
| Regents University of California Los AngelesLos Angeles, CA | Characterizing ptprz1 mechanism in cancer as a therapeutic target, 3rd year funding | $50K |
| The UCLA FoundationLos Angeles, CA | Hapten-modified neoantigens as immune targets for glioblastoma treatment | $50K |
| The University of Texas MD Anderson Cancer CenterHouston, TX | Project fp00009152 - Repurposing migraine treatments for dipg - 5th year funding | $50K |
| The University of Texas MD Anderson Cancer CenterHouston, TX | Autophagy inhibition to sensitize medulloblastoma to enhance nk cell immunotherapy | $50K |
| University of Alabama at BirminghamBirmingham, AL | Targeting recurrent glioblastoma cells using collagen-binding il-12 and il-7 | $50K |
| University of California San FranciscoSan Francisco, CA | Defining neural dependent vulnerabilities in gbm radiation sensitization using functional genomics | $50K |
| University of Southern CaliforniaLos Angeles, CA | The role of gaba transaminase in medulloblastoma local recurrence and its potential as a therapeutic target in medulloblastoma metastasis 3rd year funding | $50K |
| Duke UniversityDurham, NC | "the care-bear proposal." 2nd year renewal; portion transferred to university of colorado. Remaining funds reimbursed and then allocated to university of colorado regents. | $34K |
| Regents of the University of ColoradoAurora, CO | "the care-bear proposal." 2nd year renewal | $16K |
| Brain Tumor Epidemiology ConsortiumHinsdale, IL | Characterizing ptprz1 mechanism in cancer as a therapeutic target, 3rd year funding | $5K |
| Central Brain Tumor Registry of the United StatesHinsdale, IL | General support | $5K |
| The UCLA FoundationLos Angeles, CA | To support the work of dr. Cloughesy and dr. Liau at the brain tumor center of ucla. | $579 |
Crossref funder 100019451 · EIN 46-4485313 · ROR 02p6wqg36